Northwire Canada EditionSaturday, October 17, 2026
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%
M&A / Property

Eshbal Signs with Leading U.S. Food Broker Active Marketing Group to Scale Distribution; Grants Performance Equity

ESBL · Price

Executive Summary

  • Eshbal Functional Food Inc. entered a sales and marketing agreement with Active Marketing Group (AMG) to launch its gluten‑free Barili products across major U.S. retail channels, marking the company’s first scaled entry into the United States.
  • The partnership is supported by AMG’s 37‑year track record and relationships with retailers such as Walmart, Target, and CVS, providing a strong go‑to‑market platform for Eshbal’s “better‑for‑you” product line.
  • Concurrently, Eshbal granted 1,260,000 incentive stock options and 741,000 restricted share units to directors and officers under its Omnibus Incentive Plan, with an exercise price of $0.25 per share.

Key Details

  • Sales & Marketing Agreement
  • AMG will represent Eshbal’s flagship gluten‑free Barili products and additional future SKUs in the U.S. market.
  • Scope includes placement in grocery, natural, mass‑market, online, and specialty retailers nationwide.
  • The agreement is intended to build distribution, brand awareness, and sell‑through for Eshbal’s “better‑for‑you” food category.

  • Strategic Rationale

  • Provides Eshbal with immediate access to AMG’s extensive retailer network (e.g., Walmart, Target, Publix, CVS, Sam’s Club, Meijer).
  • Supports the company’s corporate growth strategy of expanding into the multi‑billion‑dollar gluten‑free market.

  • Equity Compensation

  • Total granted: 1,260,000 incentive stock options (Options) and 741,000 restricted share units (RSUs).
  • Options: Exercise price $0.25 per common share; exercisable for up to five years from grant date.
  • RSUs vesting schedule:
    • 251,520 RSUs – 50 % vest immediately; remaining half in six equal monthly installments over the next 6 months.
    • 490,000 RSUs – vested in equal monthly installments over the next 12 months.
  • Grants were made to certain directors and officers (560,000 Options and 621,520 RSUs).

  • Company Background

  • Reported 2024 revenues of > US$11 million.
  • Positions itself as an innovative, profitable food‑tech company with a broad gluten‑free product portfolio.

Notable Quotes

  • “This partnership marks an important milestone in our go‑to‑market plan for North America… creates a strong foundation for the U.S. launch of Barili and other Eshbal brands.” – Avi Markus, Chief Commercial Officer, Eshbal
  • “Eshbal’s pita delivers the closest experience we’ve seen to traditional bread in a gluten‑free format…” – Todd Grisoff, President, Active Marketing Group

All forward‑looking statements are subject to risks and uncertainties; actual results may differ materially.

Read the original news release →

More from Eshbal Functional Food Inc.